CN104892723B - Preparation method of hairtail liver antibacterial peptide - Google Patents
Preparation method of hairtail liver antibacterial peptide Download PDFInfo
- Publication number
- CN104892723B CN104892723B CN201510238562.4A CN201510238562A CN104892723B CN 104892723 B CN104892723 B CN 104892723B CN 201510238562 A CN201510238562 A CN 201510238562A CN 104892723 B CN104892723 B CN 104892723B
- Authority
- CN
- China
- Prior art keywords
- hairtail
- chromatography
- liver
- cell membrane
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001125843 Trichiuridae Species 0.000 title claims description 33
- 210000004185 liver Anatomy 0.000 title claims description 30
- 238000002360 preparation method Methods 0.000 title claims description 24
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims description 15
- 210000000170 cell membrane Anatomy 0.000 claims description 31
- 230000002255 enzymatic effect Effects 0.000 claims description 21
- 238000004007 reversed phase HPLC Methods 0.000 claims description 20
- 238000011140 membrane chromatography Methods 0.000 claims description 19
- 239000011347 resin Substances 0.000 claims description 19
- 229920005989 resin Polymers 0.000 claims description 19
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 18
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 18
- 238000000108 ultra-filtration Methods 0.000 claims description 16
- 241000194107 Bacillus megaterium Species 0.000 claims description 14
- 238000001641 gel filtration chromatography Methods 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 14
- 230000000844 anti-bacterial effect Effects 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 12
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 11
- 239000000413 hydrolysate Substances 0.000 claims description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 239000012154 double-distilled water Substances 0.000 claims description 9
- 238000010828 elution Methods 0.000 claims description 9
- 230000005764 inhibitory process Effects 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 6
- 238000002835 absorbance Methods 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000000825 ultraviolet detection Methods 0.000 claims description 6
- 229920005654 Sephadex Polymers 0.000 claims description 5
- 239000012507 Sephadex™ Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 108090000145 Bacillolysin Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000035092 Neutral proteases Human genes 0.000 claims description 3
- 108091005507 Neutral proteases Proteins 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 239000008055 phosphate buffer solution Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 238000002137 ultrasound extraction Methods 0.000 claims 1
- 241000894006 Bacteria Species 0.000 description 5
- 241000589540 Pseudomonas fluorescens Species 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000014133 Antimicrobial Cationic Peptides Human genes 0.000 description 1
- 108010050820 Antimicrobial Cationic Peptides Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000593508 Garcinia Species 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- TXTZMVNJIRZABH-ULQDDVLXSA-N Lys-Val-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TXTZMVNJIRZABH-ULQDDVLXSA-N 0.000 description 1
- RPVDDQYNBOVWLR-HOCLYGCPSA-N Trp-Gly-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O RPVDDQYNBOVWLR-HOCLYGCPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000000816 peptidomimetic Substances 0.000 description 1
- 108010083476 phenylalanyltryptophan Proteins 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明公开了一种带鱼肝脏抗菌肽的制备方法,该制备时以带鱼肝脏作为原料,经肝脏粗蛋白抽提、酶解、超滤和色谱制备,得抗菌肽。抗菌肽的氨基酸序列为Lys‑Val‑Phe‑Trp‑Gly‑Leu‑His‑Pro,ESI‑MS检测分子量为983.15 Da。本发明制备的抗菌肽Lys‑Val‑Phe‑Trp‑Gly‑Leu‑His‑Pro对革兰氏阴性菌、荧光假单孢菌、绿脓杆菌和革兰氏阳性菌、巨大芽孢杆菌、藤黄八叠球菌均有较强的抑制作用。
The invention discloses a preparation method of hairtail liver antibacterial peptide. During the preparation, hairtail liver is used as a raw material, and the antibacterial peptide is obtained through liver crude protein extraction, enzymatic hydrolysis, ultrafiltration and chromatography. The amino acid sequence of the antimicrobial peptide is Lys‑Val‑Phe‑Trp‑Gly‑Leu‑His‑Pro, and the molecular weight detected by ESI‑MS is 983.15 Da. The antibacterial peptide Lys-Val-Phe-Trp-Gly-Leu-His-Pro prepared by the present invention is effective against Gram-negative bacteria, Pseudomonas fluorescens, Pseudomonas aeruginosa and Gram-positive bacteria, Bacillus megaterium, Luccinia cambogia Sarcinus has a strong inhibitory effect.
Description
技术领域technical field
本发明涉及一种鱼类内脏活性多肽的制备方法,尤其涉及带鱼肝脏抗菌肽的制备方法。The invention relates to a preparation method of fish visceral active polypeptide, in particular to a preparation method of hairtail liver antibacterial peptide.
背景技术Background technique
抗菌肽(Antibacterial peptide,ABP)又叫抗微生物肽、多肽抗生素,是指氨基酸数目小于100,具广谱抗性的一类小肽。由于抗菌肽对细菌、真菌、寄生虫等有着广泛的抑制作用,并且随着越来越多的抗生素耐药微生物的出现,使得抗菌肽在医药行业和食品添加剂等领域有这更为良好的应用前景。抗菌肽在广义上是指存在于生物体内具有抵抗外界微生物侵害、消除体内突变细胞的一类小分子阳离子多肽。抗菌肽由生物细胞特定基因编码,经特定外界条件诱导产生。目前为止,世界上已知的抗菌肽共有 1200 多种,而以天然阳离子抗菌肽作模板进行人工合成的模拟肽有数千种。Antibacterial peptides (ABPs), also known as antimicrobial peptides and polypeptide antibiotics, refer to a class of small peptides with less than 100 amino acids and broad-spectrum resistance. Because antimicrobial peptides have a wide range of inhibitory effects on bacteria, fungi, parasites, etc., and with the emergence of more and more antibiotic-resistant microorganisms, antimicrobial peptides have better applications in the pharmaceutical industry and food additives. prospect. In a broad sense, antimicrobial peptides refer to a class of small-molecule cationic peptides that exist in the body to resist the invasion of external microorganisms and eliminate mutant cells in the body. Antimicrobial peptides are encoded by specific genes of biological cells and induced by specific external conditions. So far, there are more than 1,200 known antimicrobial peptides in the world, and there are thousands of peptidomimetic peptides that are artificially synthesized using natural cationic antimicrobial peptides as templates.
基于此,申请人以带鱼肝脏为原料,利用现代生物技术制备抗菌肽,既增加了带鱼资源的利用率,减少了肝脏等下脚料对环境的危害,同时也为海洋抗菌药物的开发提供候选药物。Based on this, the applicant uses hairtail liver as raw material and uses modern biotechnology to prepare antimicrobial peptides, which not only increases the utilization rate of hairtail resources, reduces the harm to the environment from scraps such as liver, but also provides candidate drugs for the development of marine antibacterial drugs .
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题是提供一种工艺科学合理、易于操作、提取的多肽具有良好抗菌效果的带鱼肝脏抗菌肽的制备方法。The technical problem to be solved by the present invention is to provide a preparation method of hairtail liver antibacterial peptide with scientific and reasonable process, easy operation, and good antibacterial effect of the extracted polypeptide.
本发明为解决上述技术问题所采取的技术方案为:一种带鱼肝脏抗菌肽的制备方法,其特征在于包括以下步骤:The technical scheme adopted by the present invention to solve the above-mentioned technical problems is: a preparation method of hairtail liver antibacterial peptide, which is characterized by comprising the following steps:
1)带鱼肝脏酶解物的制备:带鱼肝脏从冰冻带鱼中取出、解冻,用高速组织捣碎机匀浆,然后按照固液比1 g:8~10mL加入磷酸盐缓冲液(0.02 mol/L,pH 6.5~7.5)混匀,加热至20~30℃,在功率为900W,频率为30~50kHz 超声波发生器内超声提取90~120 min,按照肝脏质量的0.3~0.5%加入中性蛋白酶(酶活力≥2.0×104 U/g),于温度55~65℃下酶解6~8 h,10 000 r/min离心25~30 min,取上清液采用3 kDa超滤膜进行超滤处理,收集分子量小于3 kDa部分,冷冻干燥,得超滤酶解物;1) Preparation of hairtail liver enzymolysate: hairtail liver was taken out from frozen hairtail, thawed, homogenized with a high-speed tissue masher, and then added with phosphate buffer (0.02 mol/L) according to a solid-liquid ratio of 1 g: 8-10 mL. , pH 6.5-7.5), mix well, heat to 20-30°C, ultrasonically extract for 90-120 min in an ultrasonic generator with a power of 900W and a frequency of 30-50kHz, and add neutral protease (0.3-0.5% of the liver mass). Enzyme activity ≥ 2.0×10 4 U/g), enzymatic hydrolysis at 55-65°C for 6-8 h, centrifugation at 10 000 r/min for 25-30 min, and the supernatant was collected using a 3 kDa ultrafiltration membrane for ultrafiltration Process, collect the fraction with molecular weight less than 3 kDa, freeze-dry to obtain ultrafiltration enzymatic hydrolysate;
2)带鱼肝脏抗菌肽的制备:将制备的带鱼肝脏超滤酶解物依次经大孔树脂除杂、凝胶过滤层析、细胞膜色谱纯化和反相高效液相色谱(RP-HPLC)制备,得到带鱼肝脏抗菌肽。2) Preparation of antibacterial peptides from hairtail liver: The prepared hairtail liver ultrafiltration enzymatic hydrolyzate was sequentially prepared by macroporous resin removal, gel filtration chromatography, cell membrane chromatography purification and reversed-phase high performance liquid chromatography (RP-HPLC), Get hairtail liver antibacterial peptides.
作为优选,所述步骤1)中的带鱼为带鱼(Ttichiutus haumela)。Preferably, the hairtail in the step 1) is hairtail ( Ttichiutus haumela ).
作为优选,所述步骤2)中的大孔树脂除杂、凝胶过滤层析、细胞膜色谱纯化和反相高效液相色谱(RP-HPLC)制备的具体过程为:Preferably, the specific process of macroporous resin removal, gel filtration chromatography, cell membrane chromatography purification and reversed-phase high performance liquid chromatography (RP-HPLC) preparation in the step 2) is as follows:
大孔树脂除杂:将得到的超滤酶解物用双蒸水制成浓度为10~15 mg/mL溶液,以2~3 mL/min的流速加入到D201大孔树脂层析柱,用2~3倍柱体积的双蒸水洗脱除去杂质,然后用3~5倍柱体积75%乙醇进行洗脱,洗脱液于50 ℃以下低压旋蒸除去乙醇后,冷冻干燥得大孔树脂制备酶解物。Removal of impurities by macroporous resin: The obtained ultrafiltration enzymolysate was made into a solution with a concentration of 10-15 mg/mL with double distilled water, and was added to a D201 macroporous resin chromatography column at a flow rate of 2-3 mL/min. 2 to 3 times the column volume of double-distilled water to remove impurities, and then 3 to 5 times the column volume of 75% ethanol for elution, the eluent is rotated at a low pressure below 50 ℃ to remove the ethanol, and freeze-dried to obtain a macroporous resin Preparation of enzymatic hydrolysate.
凝胶过滤层析:将上述大孔树脂制备酶解物溶于三蒸水配成浓度为10~15 mg/mL的溶液,经过葡聚糖凝胶G-25柱层析分离,用三蒸水进行洗脱,根据225 nm下的吸光度曲线收集洗脱组分,其中,对大肠杆菌(Escherichia coli)和巨大芽孢杆菌(Bacillus megaterium)抑制率最高组分为凝胶过滤层析酶解物。Gel filtration chromatography: Dissolve the enzymatic hydrolyzate prepared from the macroporous resin above in triple-distilled water to make a solution with a concentration of 10-15 mg/mL, and separate it by Sephadex G-25 column chromatography, and use triple-distilled water for separation. After elution, the eluted fractions were collected according to the absorbance curve at 225 nm, among which, the fraction with the highest inhibition rate against Escherichia coli ( Escherichia coli ) and Bacillus megaterium ( Bacillus megaterium ) was gel filtration chromatography enzymatic hydrolysate.
细胞膜色谱纯化:将上述凝胶过滤层析酶解物用三蒸水配成80~100 μg/mL的溶液,加入到细胞膜色谱柱进行纯化,根据225 nm下的吸光度曲线收集洗脱组分,其中,对大肠杆菌(Escherichia coli)和巨大芽孢杆菌(Bacillus megaterium)抑制率最高组分为细胞膜色谱纯化酶解物。Purification by Cell Membrane Chromatography: The above gel filtration chromatography enzymolysate was made into a solution of 80-100 μg/mL with triple distilled water, added to a cell membrane chromatography column for purification, and the eluted fractions were collected according to the absorbance curve at 225 nm. Among them, the components with the highest inhibition rate to Escherichia coli and Bacillus megaterium are the enzymatic hydrolysates purified by cell membrane chromatography.
RP-HPLC制备:将上述细胞膜色谱纯化酶解物用双蒸水配成80~100 μg/mL的溶液,利用RP-HPLC进行纯化,根据对大肠杆菌(Escherichia coli)和巨大芽孢杆菌(Bacillus megaterium)的抑制率得1个高活性抗菌肽Lys-Val-Phe-Trp-Gly-Leu-His-Pro(KVFWGLHP)。RP-HPLC preparation: The above-mentioned cell membrane chromatography-purified enzymatic hydrolysate was prepared into a solution of 80-100 μg /mL with double distilled water, and purified by RP-HPLC. ) was a highly active antimicrobial peptide Lys-Val-Phe-Trp-Gly-Leu-His-Pro (KVFWGLHP).
优选,所述细胞膜色谱条件为:细胞膜为巨大芽孢杆菌(Bacillus megaterium)的细胞膜;进样量为15~20 μL;细胞膜色谱柱(150 mm × 4.6mm,5 μm);柱温为37 ℃;流动相为三蒸水;紫外检测波长225 nm;流速为0.3~0.5 mL/min。Preferably, the cell membrane chromatography conditions are: the cell membrane is the cell membrane of Bacillus megaterium ; the injection volume is 15-20 μL; the cell membrane chromatography column (150 mm × 4.6 mm, 5 μm); the column temperature is 37 °C; The mobile phase was triple distilled water; the UV detection wavelength was 225 nm; the flow rate was 0.3-0.5 mL/min.
优选,所述RP-HPLC条件为:进样量为15~20 μL;色谱柱为Zorbax C18(250 mm ×4.6mm,5 μm);流动相为20%乙腈(含0.1%三氟乙酸);洗脱速度为0.8~1.0 mL/min;紫外检测波长为225 nm。Preferably, the RP-HPLC conditions are: the injection volume is 15-20 μL; the chromatographic column is Zorbax C18 (250 mm × 4.6 mm, 5 μm); the mobile phase is 20% acetonitrile (containing 0.1% trifluoroacetic acid); The elution rate was 0.8-1.0 mL/min; the UV detection wavelength was 225 nm.
与现有技术相比,本发明的优点在于:Compared with the prior art, the advantages of the present invention are:
(1)本发明以带鱼肝脏为原料,提高了带鱼资源的利用率,减少了环境污染。(1) The present invention uses hairtail liver as raw material, which improves the utilization rate of hairtail resources and reduces environmental pollution.
(2)本发明制备的抗菌肽Lys-Val-Phe-Trp-Gly-Leu-His-Pro(KVFWGLHP)对革兰氏阴性菌(G-)(大肠杆菌(Escherichia coli)、荧光假单孢菌(Pseudomonas fluorescens)、绿脓杆菌(Pseudomonas aeruginosa))和革兰氏阳性菌(G+)(金黄色葡萄球(Staphylococcus aureus)、巨大芽孢杆菌(Bacillus megaterium)、藤黄八叠球菌(Sarcina lutea))均有较强的抑制作用,且安全性高,可应用于医药、化妆品和食品等行业。(2) The antimicrobial peptide Lys-Val-Phe-Trp-Gly-Leu-His-Pro (KVFWGLHP) prepared by the present invention is effective against Gram - negative bacteria (G-) ( Escherichia coli ), Pseudomonas fluorescens ( Pseudomonas fluorescens ), Pseudomonas aeruginosa ) and Gram-positive bacteria (G + ) ( Staphylococcus aureus , Bacillus megaterium , Sarcina lutea ) ) have strong inhibitory effect and high safety, and can be used in medicine, cosmetics and food industries.
附图说明Description of drawings
图1是本发明步骤流程示意图;Fig. 1 is the step flow schematic diagram of the present invention;
图2是本发明大孔树脂制备酶解物的葡聚糖凝胶G-25层析图;Fig. 2 is the Sephadex G-25 chromatogram of the macroporous resin of the present invention to prepare the enzymatic hydrolysate;
图3是本发明的葡聚糖凝胶G-25制备酶解物(Fr.C)的细胞膜色谱图。Fig. 3 is a cell membrane chromatogram of the enzymatic hydrolyzate (Fr.C) prepared by Sephadex G-25 of the present invention.
图4是本发明的细胞膜色谱制备酶解物(Fr.C-I)的反相高效液相色谱(RP-HPLC)图。Fig. 4 is a reversed-phase high performance liquid chromatography (RP-HPLC) diagram of the enzymatic hydrolyzate (Fr.C-I) prepared by cell membrane chromatography of the present invention.
具体实施方式Detailed ways
以下结合实施例对本发明作进一步详细描述。The present invention will be described in further detail below in conjunction with the embodiments.
一种带鱼肝脏抗菌肽的制备方法,制备工艺流程如下:带鱼肝脏→蛋白抽提、酶解→超滤→大孔树脂除杂→凝胶过滤层析→细胞膜色谱纯化→高效液相色谱制备→抗菌肽。A method for preparing antibacterial peptides from hairtail liver. The preparation process is as follows: hairtail liver → protein extraction, enzymatic hydrolysis → ultrafiltration → macroporous resin impurity removal → gel filtration chromatography → cell membrane chromatography purification → high performance liquid chromatography preparation → Antimicrobial Peptides.
实施例:Example:
1)带鱼肝脏酶解物的制备:带鱼(Ttichiutus haumela)肝脏从冰冻带鱼中取出、解冻,用高速组织捣碎机匀浆,然后按照固液比1 g: 10mL加入磷酸盐缓冲液(0.02 mol/L,pH 7.0)混匀,加热至25℃,在功率为900W,频率为40kHz 超声波发生器内超声提取120min,按照肝脏质量的0.5%加入中性蛋白酶(酶活力≥2.0×104 U/g),于温度60℃下酶解8h,10 000 r/min离心30 min,取上清液采用3 kDa超滤膜进行超滤处理,收集分子量小于3kDa部分,冷冻干燥,得超滤酶解物;1) Preparation of hairtail liver enzymolysate: hairtail ( Ttichiutus haumela ) liver was taken out from frozen hairtail, thawed, homogenized with a high-speed tissue masher, and then added with phosphate buffer (0.02 mol) according to the solid-to-liquid ratio of 1 g: 10 mL /L, pH 7.0), mix well, heat to 25°C, ultrasonically extract for 120min in an ultrasonic generator with a power of 900W and a frequency of 40kHz, and add neutral protease (enzyme activity ≥2.0×10 4 U/L) according to 0.5% of the liver mass. g), enzymolyzed at 60°C for 8 hours, centrifuged at 10 000 r/min for 30 min, took the supernatant for ultrafiltration with a 3 kDa ultrafiltration membrane, collected the fraction with molecular weight less than 3 kDa, freeze-dried, and obtained ultrafiltration enzymatic hydrolysis thing;
2)带鱼肝脏抗菌肽的制备:将制备的带鱼肝脏超滤酶解物依次经大孔树脂除杂、凝胶过滤层析、细胞膜色谱纯化和反相高效液相色谱(RP-HPLC)制备,得到带鱼肝脏抗菌肽。2) Preparation of antibacterial peptides from hairtail liver: The prepared hairtail liver ultrafiltration enzymatic hydrolyzate was sequentially prepared by macroporous resin removal, gel filtration chromatography, cell membrane chromatography purification and reversed-phase high performance liquid chromatography (RP-HPLC), Get hairtail liver antibacterial peptides.
①大孔树脂除杂:将得到的超滤酶解物用双蒸水制成浓度为15 mg/mL溶液,以3mL/min的流速加入到D201大孔树脂层析柱,用2倍柱体积的双蒸水洗脱除去杂质,然后用5倍柱体积75%乙醇进行洗脱,洗脱液于50 ℃以下低压旋蒸除去乙醇后,冷冻干燥得大孔树脂制备酶解物。①Removal of impurities by macroporous resin: The obtained ultrafiltration enzymolysate was made into a solution with a concentration of 15 mg/mL with double distilled water, and added to a D201 macroporous resin chromatography column at a flow rate of 3 mL/min, using 2 times the column volume The impurities were removed by elution with double-distilled water, and then eluted with 5 times the column volume of 75% ethanol. The eluate was evaporated at a low pressure below 50 °C to remove the ethanol, and then freeze-dried to obtain a macroporous resin to prepare the enzymatic hydrolyzate.
②凝胶过滤层析:将上述大孔树脂制备酶解物溶于三蒸水配成浓度为15 mg/mL的溶液,经过葡聚糖凝胶G-25柱层析分离,用三蒸水进行洗脱,根据225 nm下的吸光度曲线收集洗脱组分,其中,对大肠杆菌(Escherichia coli)和巨大芽孢杆菌(Bacillus megaterium)抑制率最高组分为凝胶过滤层析酶解物Fr.C(图2)。②Gel filtration chromatography: The enzymatic hydrolyzate prepared from the macroporous resin was dissolved in triple-distilled water to make a solution with a concentration of 15 mg/mL, separated by Sephadex G-25 column chromatography, and washed with triple-distilled water. The eluted fractions were collected according to the absorbance curve at 225 nm, among which, the fraction with the highest inhibition rate to Escherichia coli and Bacillus megaterium was gel filtration chromatography enzymatic hydrolysate Fr.C ( figure 2).
③细胞膜色谱纯化:将上述凝胶过滤层析酶解物用三蒸水配成100 μg/mL的溶液,加入到细胞膜色谱柱进行纯化(条件:细胞膜为巨大芽孢杆菌(Bacillus megaterium)的细胞膜;进样量为15 μL;细胞膜色谱柱(150 mm × 4.6mm,5 μm);柱温为37 ℃;流动相为三蒸水;紫外检测波长225 nm;流速为0.3 mL/min),根据225 nm下的吸光度曲线收集洗脱组分,其中,对大肠杆菌(Escherichia coli)和巨大芽孢杆菌(Bacillus megaterium)抑制率最高组分为细胞膜色谱纯化酶解物Fr.C-I(图3)。③ Purification by Cell Membrane Chromatography: The above gel filtration chromatography enzymolysate was prepared into a solution of 100 μg/mL with three distilled water, and added to the cell membrane chromatography column for purification (condition: the cell membrane is the cell membrane of Bacillus megaterium ); The injection volume was 15 μL; the cell membrane column (150 mm × 4.6 mm, 5 μm); the column temperature was 37 °C; the mobile phase was triple distilled water; the UV detection wavelength was 225 nm; the flow rate was 0.3 mL/min), according to 225 The absorbance curve under nm was used to collect the eluted fractions. Among them, the fraction with the highest inhibition rate against Escherichia coli and Bacillus megaterium was the cell membrane chromatography-purified enzymatic hydrolysate Fr.CI (Figure 3).
④RP-HPLC制备:将上述细胞膜色谱纯化酶解物用双蒸水配成100 μg/mL的溶液,利用RP-HPLC进行纯化(条件:进样量为20 μL;色谱柱为Zorbax C18(250 mm × 4.6mm,5 μm);流动相为20%乙腈(含0.1%三氟乙酸);洗脱速度为0.8 mL/min;紫外检测波长为225nm),根据对大肠杆菌(Escherichia coli)和巨大芽孢杆菌(Bacillus megaterium)抑制率得1个高活性抗菌肽(图4)。④ RP-HPLC preparation: The above-mentioned cell membrane chromatography-purified enzymatic hydrolysate was made into a 100 μg/mL solution with double distilled water, and purified by RP-HPLC (condition: the injection volume was 20 μL; the chromatographic column was Zorbax C18 (250 mm) × 4.6mm, 5 μm); mobile phase is 20% acetonitrile (containing 0.1% trifluoroacetic acid); elution rate is 0.8 mL/min; UV detection wavelength is 225 nm), according to Escherichia coli and Megaspore Bacillus ( Bacillus megaterium ) inhibition rate was a highly active antimicrobial peptide (Figure 4).
⑤结构测定:高活性抗菌肽经检测为单一峰,利用蛋白/多肽序列分析仪测定氨基酸序列为Lys-Val-Phe-Trp-Gly-Leu-His-Pro (KVFWGLHP),ESI-MS检测分子量为983.15Da。⑤Structure determination: The highly active antimicrobial peptide was detected as a single peak, and the amino acid sequence determined by protein/peptide sequence analyzer was Lys-Val-Phe-Trp-Gly-Leu-His-Pro (KVFWGLHP), and the molecular weight detected by ESI-MS was 983.15Da.
⑥抑菌活性测定:如表1所示:抗菌肽Lys-Val-Phe-Trp-Gly-Leu-His-Pro(KVFWGLHP)对革兰氏阴性菌(G-)(大肠杆菌(Escherichia coli)、荧光假单孢菌(Pseudomonas fluorescens)、绿脓杆菌(Pseudomonas aeruginosa))和革兰氏阳性菌(G+)(金黄色葡萄球(Staphylococcus aureus)、巨大芽孢杆菌(Bacillus megaterium)、藤黄八叠球菌(Sarcina lutea))均有较强的抑制作用,具有广谱抑菌性,其中对G-菌抑菌效果总体强于G+菌。⑥ Determination of antibacterial activity: as shown in Table 1: antimicrobial peptide Lys-Val-Phe-Trp-Gly-Leu-His-Pro (KVFWGLHP) against Gram - negative bacteria (G-) ( Escherichia coli ), Pseudomonas fluorescens , Pseudomonas aeruginosa ) and Gram-positive bacteria (G + ) ( Staphylococcus aureus ), Bacillus megaterium , Garcinia Coccus ( Sarcina lutea )) has a strong inhibitory effect, with broad-spectrum antibacterial activity, and the antibacterial effect on G - bacteria is generally stronger than that of G + bacteria.
表1抗菌肽Lys-Val-Phe-Trp-Gly-Leu-His-Pro(KVFWGLHP)的抑菌谱(n = 3)Table 1 Antibacterial spectrum of antimicrobial peptide Lys-Val-Phe-Trp-Gly-Leu-His-Pro (KVFWGLHP) (n = 3)
注:灭菌打孔器(直径=4mm)打孔,每孔加入抗菌液20 μL;表中数据为抑菌圈直径平均值±标准差(n=3)。Note: A sterilization hole punch (diameter = 4mm) was used to punch holes, and 20 μL of antibacterial solution was added to each hole; the data in the table are the mean ± standard deviation of the diameter of the inhibition zone (n = 3).
最后,尚需注意的是,以上列举的仅是本发明的一个具体实施例。显然,本发明不限于以上实施例,还可以有许多变形。本领域的普通技术人员能从本发明公开的内容直接导出或联想到的所有变形,均应认为是本发明的保护范围。Finally, it should be noted that the above list is only a specific embodiment of the present invention. Obviously, the present invention is not limited to the above embodiments, and many modifications are possible. All deformations that those of ordinary skill in the art can directly derive or associate from the disclosure of the present invention shall be considered as the protection scope of the present invention.
SEQUENCE LISTINGSEQUENCE LISTING
<110> 浙江海洋学院<110> Zhejiang Ocean University
<120> 带鱼肝脏抗菌肽的制备方法<120> Preparation method of hairtail liver antibacterial peptide
<130> zjou-2015-wb0505<130> zjou-2015-wb0505
<160> 1<160> 1
<170> PatentIn version 3.5<170> PatentIn version 3.5
<210> 1<210> 1
<211> 8<211> 8
<212> PRT<212> PRT
<213> 人工合成<213> Synthetic
<400> 1<400> 1
Lys Val Phe Trp Gly Leu His ProLys Val Phe Trp Gly Leu His Pro
1 51 5
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510238562.4A CN104892723B (en) | 2015-05-12 | 2015-05-12 | Preparation method of hairtail liver antibacterial peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510238562.4A CN104892723B (en) | 2015-05-12 | 2015-05-12 | Preparation method of hairtail liver antibacterial peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104892723A CN104892723A (en) | 2015-09-09 |
CN104892723B true CN104892723B (en) | 2020-11-10 |
Family
ID=54025732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510238562.4A Active CN104892723B (en) | 2015-05-12 | 2015-05-12 | Preparation method of hairtail liver antibacterial peptide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104892723B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110724175B (en) * | 2019-10-14 | 2021-10-22 | 浙江海洋大学 | A preparation method for extracting antimicrobial peptides from blue mussel leftovers by using ultrasonic homogenization |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103388014A (en) * | 2012-05-11 | 2013-11-13 | 浙江海洋学院 | Preparation method for ferrous chelated antibacterial peptide |
CN104726526A (en) * | 2015-03-02 | 2015-06-24 | 广东海洋大学 | Method for preparing bioactive peptide for treating wound healing by using fish skins |
-
2015
- 2015-05-12 CN CN201510238562.4A patent/CN104892723B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103388014A (en) * | 2012-05-11 | 2013-11-13 | 浙江海洋学院 | Preparation method for ferrous chelated antibacterial peptide |
CN104726526A (en) * | 2015-03-02 | 2015-06-24 | 广东海洋大学 | Method for preparing bioactive peptide for treating wound healing by using fish skins |
Non-Patent Citations (2)
Title |
---|
基于肽-膜相互作用的模拟细胞膜法筛选抗菌肽的研究;唐文婷;《中国博士学位论文全文数据库 工程科技I辑》;20150315;摘要;第48页3.3.11 * |
超滤法制备高抗菌抗氧化活性带鱼蛋白亚铁螯合肽(Fe-HPH)的工艺研究;林慧敏等;《中国食品学报》;20120630;第12卷(第6期);摘要 * |
Also Published As
Publication number | Publication date |
---|---|
CN104892723A (en) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104250285B (en) | Pseudosciaena crocea flesh antioxidative peptide and preparation method and use thereof | |
CN103992384B (en) | A kind of large yellow croaker fish bone collagen peptide and its production and use | |
CN103937864B (en) | An active polypeptide isolated from anchovy | |
CN104710511B (en) | Iron chelating peptide derived from hairtail fish protein and preparation method and application thereof | |
CN103980347A (en) | Antihypertensive peptide of swim bladder of large yellow croaker and preparation method and use thereof | |
CN104250286B (en) | Navodon septentrionalis fish-skin antioxidant collagen peptide and preparation method and use thereof | |
CN104774899B (en) | Preparation method of tuna dark meat protein anti-cervical cancer polypeptide | |
CN104892730B (en) | Hairtail liver antibacterial peptide | |
CN104558115A (en) | Antioxidant polypeptide with Raja porosa meat protein as well as preparation method and application of antioxidant polypeptide | |
CN108893515A (en) | high F value oligopeptide and preparation method thereof | |
CN103992386A (en) | Pseudosciaena crocea fish scale oxidation-resistant collagen peptide, and preparation method and application thereof | |
CN104892723B (en) | Preparation method of hairtail liver antibacterial peptide | |
CN102643889A (en) | Antihypertensive active rapeseed peptide and preparation method and application thereof | |
CN105061575B (en) | Tuna liver antibacterial peptide and preparation method and application thereof | |
CN105648010A (en) | Preparation method of Sphyrna lewini meat antioxidative peptides capable of activating Nrf2-ARE pathway | |
CN105198962B (en) | Defatted Crab Shell Antioxidant Peptides | |
CN105648004A (en) | Preparation method of dasyatis akajei cartilage antioxidative collagen peptide | |
CN105175495B (en) | Application of defatted crab shell antioxidant peptide | |
CN108220273A (en) | A kind of antimicrobial peptide mixture and its preparation method and application | |
CN104894200B (en) | Preparation method of cartilage angiogenesis inhibiting factor of Sphyrna lewini | |
CN102676621A (en) | Antihypertensive rapeseed peptide and preparation method and application of antihypertensive rapeseed peptide | |
CN104886718B (en) | Application of a kind of hairtail liver antibacterial peptide | |
CN102212513B (en) | Proteolytic enzyme separated from cordyceps sinensis and purification method thereof | |
CN105200104A (en) | Method for preparing antioxidative peptide chain by utilizing crab shell offal | |
CN104928337A (en) | Navodon fishskin zinc chelating peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |